Condition
Immunotherapy, Active clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Immunotherapy, Active clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Effect of BCG and Tislelizumab on Bladder Cancer
This study is testing if combining a vaccine called BCG with a new drug called tislelizumab can help people with intermediate and high-risk bladder cancer have fewer recurrences after surgery.
-
New imaging methods for detecting brain tumors in patients with metastasis
This study is testing new imaging techniques to see if they can better detect brain tumors in patients who have cancer that has spread to the brain.
Related topics
Quick answers
How many Immunotherapy, Active clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.